Patents by Inventor Syuichi Segawa

Syuichi Segawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11752180
    Abstract: The present invention provides an intestinal tract protective agent comprising a polyphosphoric acid or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: August 6, 2020
    Date of Patent: September 12, 2023
    Assignees: National University Corporation Asahikawa Medical University, Sapporo Holdings Limited
    Inventors: Yutaka Kohgo, Mikihiro Fujiya, Nobuhiro Ueno, Syuichi Segawa, Naoyuki Kobayashi
  • Publication number: 20200368299
    Abstract: The present invention provides an intestinal tract protective agent comprising a polyphosphoric acid or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: August 6, 2020
    Publication date: November 26, 2020
    Applicants: National University Corporation Asahikawa Medical University, Sapporo Holdings Limited
    Inventors: Yutaka Kohgo, Mikihiro Fujiya, Nobuhiro Ueno, Syuichi Segawa, Naoyuki Kobayashi
  • Patent number: 10792315
    Abstract: The present invention provides an intestinal tract protective agent comprising a polyphosphoric acid or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: March 28, 2011
    Date of Patent: October 6, 2020
    Assignees: National University Corporation Asahikawa Medical University, Sapporo Holdings Limited
    Inventors: Yutaka Kohgo, Mikihiro Fujiya, Nobuhiro Ueno, Syuichi Segawa, Naoyuki Kobayashi
  • Patent number: 10306908
    Abstract: It is an object of the present invention to provide a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which has more potent antiallergic activity than the known lactic acid bacteria strains and produces ?-aminobutyric acid (GABA). It is another object of the present invention to provide beverages and foods containing cells of the aforementioned bacterial strain belonging to Lactobacillus brevis subspecies brevis, as well as antiallergic agents containing them as an active ingredient. The present invention provides a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which: is capable of growing in effervescent alcoholic beverages, produces ?-aminobutyric acid (GABA), and has antiallergic activity.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: June 4, 2019
    Assignee: Sapporo Holdings Limited
    Inventors: Syuichi Segawa, Yasukazu Nakakita, Yoshihiro Takata, Hisako Yasui
  • Publication number: 20150208709
    Abstract: It is an object of the present invention to provide a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which has more potent antiallergic activity than the known lactic acid bacteria strains and produces ?-aminobutyric acid (GABA). It is another object of the present invention to provide beverages and foods containing cells of the aforementioned bacterial strain belonging to Lactobacillus brevis subspecies brevis, as well as antiallergic agents containing them as an active ingredient. The present invention provides a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which: is capable of growing in effervescent alcoholic beverages, produces ?-aminobutyric acid (GABA), and has antiallergic activity.
    Type: Application
    Filed: April 9, 2015
    Publication date: July 30, 2015
    Applicant: SAPPORO BREWERIES LIMITED
    Inventors: Syuichi SEGAWA, Yasukazu Nakakita, Yoshihiro Takata, Hisako Yasui
  • Patent number: 8747836
    Abstract: The present invention provides an agent for inhibition of alcoholic hepatopathy comprising cells of a strain belonging to Lactobacillus brevis, or treated product thereof as an active ingredient. The agent for inhibition of alcoholic hepatopathy of the present invention is safe for living body and can be used as a component in foods and beverages.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: June 10, 2014
    Assignee: Sapporo Breweries Limited
    Inventors: Syuichi Segawa, Yoshihisa Wakita
  • Publication number: 20130171118
    Abstract: The present invention provides an intestinal tract protective agent comprising a polyphosphoric acid or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: March 28, 2011
    Publication date: July 4, 2013
    Applicants: SAPPORO BREWERIES LIMITED, National University Corporation ASAHIKAWA MEDICAL UNIVERSITY
    Inventors: Yutaka Kohgo, Mikihiro Fujiya, Nobuhiro Ueno, Syuichi Segawa, Naoyuki Kobayashi
  • Publication number: 20110165272
    Abstract: An antiallergic composition that is moderate for the human body and skin, and has reduced side-effects that comprises a cold-water extract from hop tissue or flavonoid glucosides separated from the cold-water extract from hop tissue.
    Type: Application
    Filed: March 17, 2011
    Publication date: July 7, 2011
    Applicant: SAPPORO BREWERIES LIMITED
    Inventors: Syuichi Segawa, Kazuhisa Yasui, Nao Yasui, Toshio Kurihara
  • Patent number: 7910141
    Abstract: The present invention provides an antiallergic composition that is moderate for the human body and skin, and has reduced side-effects; the antiallergic composition comprises a cold-water extract from hop tissue or flavonoid glycosides separated from the cold-water extract.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: March 22, 2011
    Assignee: Sapporo Breweries Limited
    Inventors: Syuichi Segawa, Kazuhisa Yasui, Nao Yasui, legal representative, Toshio Kurihara
  • Publication number: 20110002901
    Abstract: It is an object of the present invention to provide a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which has more potent antiallergic activity than the known lactic acid bacteria strains and produces ?-aminobutyric acid (GABA). It is another object of the present invention to provide beverages and foods containing cells of the aforementioned bacterial strain belonging to Lactobacillus brevis subspecies brevis, as well as antiallergic agents containing them as an active ingredient. The present invention provides a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which: is capable of growing in effervescent alcoholic beverages, produces ?-aminobutyric acid (GABA), and has antiallergic activity.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 6, 2011
    Applicant: SAPPORO BREWERIES LIMITED
    Inventors: Syuichi Segawa, Yasukazu Nakakita, Yoshihiro Takata, Hisako Yasui
  • Publication number: 20100291051
    Abstract: The present invention provides an agent for inhibition of alcoholic hepatopathy comprising cells of a strain belonging to Lactobacillus brevis, or treated product thereof as an active ingredient. The agent for inhibition of alcoholic hepatopathy of the present invention is safe for living body and can be used as a component in foods and beverages.
    Type: Application
    Filed: January 14, 2009
    Publication date: November 18, 2010
    Applicant: SAPPORO BREWERIES LIMITED
    Inventors: Syuichi Segawa, Yoshihisa Wakita
  • Publication number: 20090028970
    Abstract: It is an object of the present invention to provide an antiallergic composition that is moderate for the human body and skin, and has reduced side-effects. In order to achieve this object, there is provided the antiallergic composition comprises a cold-water extract from hop tissue or flavonoid glucosides separated from the cold-water extract from hop tissue.
    Type: Application
    Filed: March 1, 2006
    Publication date: January 29, 2009
    Inventors: Syuichi Segawa, Kazuhisa Yasui, Nao Yasui, Toshio Kurihara